In-House
PrivateLast Round
Seed
May 8, 2024
Total Funding Raised
$5.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
In-House operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was a Seed round in May 2024.
In-House is a healthcare technology company that develops a predictive nurse team management platform to deliver staffing and scheduling recommendations based on clinical needs and workforce experience.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, HR, Healthcare Analytics, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
In-House Comparables
Compare In-House with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dropstat | 85% | |
| SOL Intelligence | 84% | |
| Smartlinx | 79% |
For institutional investors. Book with your work email.
In-House Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
In-House Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vine Ventures | Seed |
| New Enterprise Associates | Seed |
| Longevity Venture Partners | Pre Seed, Seed |
| TMV | Seed |
| Vine Ventures | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 92% MoM.
- Jan 1, 2026
Platform now serves over 100,000 active weekly care providers.
For institutional investors. Book with your work email.
In-House Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about In-House's valuation, stock price, and market status.
Is In-House a public or private company?
In-House is a private company.
What is the current stock price of In-House?
In-House is a private company, so its shares have no public market price. Caplight tracks In-House's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is In-House worth (valuation)?
Valuation information for In-House is not publicly available.
Can I buy In-House stock?
In-House shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was In-House's last funding round?
In-House's most recent funding round was Seed on May 8, 2024.
Who are the main investors in In-House?
Key investors in In-House include New Enterprise Associates, TMV.
Will In-House IPO soon?
No public IPO plans have been announced for In-House.
How can I track In-House secondary market activity?
Caplight tracks bids, offers, and trades in In-House's shares on secondary markets.